These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 77180

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
    Krikorian JG, Portlock CS, Rosenberg SA.
    Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
    [Abstract] [Full Text] [Related]

  • 3. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
    Kurnick JE, White M, Ware DE, Robinson WA.
    Cancer Chemother Rep; 1975 Jun; 59(6):1147-50. PubMed ID: 56989
    [Abstract] [Full Text] [Related]

  • 4. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A, Ambrosetti A, Todeschini G, Cetto G, Perona G, Cellerino R.
    Cancer Treat Rep; 1984 Jun; 68(7-8):947-51. PubMed ID: 6204754
    [Abstract] [Full Text] [Related]

  • 5. New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
    Lokich JJ, Frei E, Jaffe N, Tullis J.
    Cancer; 1976 Aug; 38(2):667-71. PubMed ID: 61797
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA.
    J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
    Harker WG, Kushlan P, Rosenberg SA.
    Ann Intern Med; 1984 Oct 15; 101(4):440-6. PubMed ID: 6206757
    [Abstract] [Full Text] [Related]

  • 8. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R, Bruntsch U, Gallmeier WM, Seeber S, Schmidt CG.
    Dtsch Med Wochenschr; 1976 Aug 06; 101(32):1177-82. PubMed ID: 59661
    [Abstract] [Full Text] [Related]

  • 9. The treatment of advanced hodgkin's disease.
    Straus DJ, Lee BJ, Koziner B, Nisce LZ, Young CW, Clarkson BD.
    Blut; 1981 Aug 06; 43(2):119-24. PubMed ID: 6167303
    [Abstract] [Full Text] [Related]

  • 10. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
    Santoro A, Bonadonna G.
    Cancer Chemother Pharmacol; 1979 Aug 06; 2(2):101-5. PubMed ID: 93984
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
    Case DC, Young CW, Lee BJ.
    Cancer; 1977 Apr 06; 39(4):1382-6. PubMed ID: 66972
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
    Wiernik PH, Schiffer CA.
    J Cancer Res Clin Oncol; 1988 Apr 06; 114(1):105-7. PubMed ID: 2450876
    [Abstract] [Full Text] [Related]

  • 13. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Santoro A, Viviani S, Valagussa P, Bonfante V, Bonadonna G.
    Semin Oncol; 1986 Mar 06; 13(1 Suppl 1):23-6. PubMed ID: 2420012
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
    Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C.
    Cancer; 1975 Jul 06; 36(1):252-9. PubMed ID: 54209
    [Abstract] [Full Text] [Related]

  • 15. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May 06; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 16. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
    Santoro A, Viviani S, Villarreal CJ, Bonfante V, Delfino A, Valagussa P, Bonadonna G.
    Cancer Treat Rep; 1986 Mar 06; 70(3):343-8. PubMed ID: 2420444
    [Abstract] [Full Text] [Related]

  • 17. MOPP treatment of resistant Hodgkin's disease following ABVD failure.
    Cimino G, Anselmo AP, Marzullo A, Maurizi Enrici R, Mauro F, Papa G, Mandelli F.
    Tumori; 1983 Oct 31; 69(5):469-72. PubMed ID: 6196891
    [Abstract] [Full Text] [Related]

  • 18. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Clamon GH, Corder MP.
    Cancer Treat Rep; 1978 Mar 31; 62(3):363-7. PubMed ID: 77188
    [No Abstract] [Full Text] [Related]

  • 19. Third-line salvage chemotherapy in Hodgkin's disease.
    Bonadonna G, Viviani S, Valagussa P, Bonfante V, Santoro A.
    Semin Oncol; 1985 Mar 31; 12(1 Suppl 2):23-5. PubMed ID: 2579440
    [Abstract] [Full Text] [Related]

  • 20. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
    Diggs CH, Wiernik PH, Levi JA, Kvols LK.
    Cancer; 1977 May 31; 39(5):1949-54. PubMed ID: 870162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.